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Collagens are members of one of the most important families of structural proteins in higher organisms. There are 28 types of collagens encoded
by 43 genes in humans that fall into several different functional protein classes. Mutations in the major fibrillar collagen genes lead to osteogenesis
imperfecta (COL1A1 and COL1A2 encoding the chains of Type I collagen), chondrodysplasias (COL2A1 encoding the chains of Type II collagen),
and vascular Ehlers–Danlos syndrome (COL3A1 encoding the chains of Type III collagen). Over the past 2 decades, mutations in these collagen
genes have been catalogued, in hopes of understanding the molecular etiology of diseases caused by these mutations, characterizing the genotype–
phenotype relationships, and developing robust models predicting the molecular and clinical outcomes. To achieve these goals better, it is necessary
to understand the natural patterns of variation in collagen genes in human populations. We screened exons, flanking intronic regions, and conserved
noncoding regions for variations in COL1A1, COL1A2, COL2A1, and COL3A1 in 48 individuals from each of four ethnically diverse populations.
We identified 459 single-nucleotide polymorphisms (SNPs), more than half of which were novel and not found in public databases. Of the 52 SNPs
found in coding regions, 15 caused amino acid substitutions while 37 did not. Although the four collagens have similar gene and protein structures,
they have different molecular evolutionary characteristics. For example, COL1A1 appears to have been under substantially stronger negative
selection than the rest. Phylogenetic analysis also suggests that the four genes have very different evolutionary histories among the different ethnic
groups. Our observations suggest that the study of collagen mutations and their relationships with disease phenotypes should be performed in the
context of the genetic background of the subjects.
© 2008 Elsevier Inc. All rights reserved.Keywords: COL1A1; COL1A2; COL2A1; COL3A1; Polymorphisms; Phylogenetics; Osteogenesis imperfectaCollagen is the most abundant protein in mammals, con-
stituting a quarter of the total protein weight [1,2]. Collagens are
grouped into families based on their structural and functional
features. Types I, II, and III collagens, the major components of
fibrillar collagens, account for 70% of the total body collagens.
Type I collagen is the major protein in bone, skin, tendon, liga-
ment, sclera and cornea tissues, blood vessels, and hollow or-
gans. Type II collagen is found in articular cartilage. Type III⁎ Corresponding author. Cardiovascular Research Institute and Institute for
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94143, USA. Fax: +1 415 476 2956.
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doi:10.1016/j.ygeno.2007.12.008collagen is often associated with Type I collagen and is a major
protein in skin, vessels, intestine, and the uterus.
Fibrillar collagens are the end product of synthesis, assembly,
secretion, and processing of pro-α chains that assemble into
trimeric proteins (procollagens) that are transported through the
cells and that, in the extracellular matrix, are converted by pro-
teolysis to collagens, which assemble into fibrillar arrays. Type I
procollagen consists of two pro-α1(I) chains (encoded by
COL1A1) and one pro-α2(I) chain (encoded by COL1A2); Type
II procollagen consists of three identical pro-α1(II) chains (en-
coded by COL2A1); and Type III procollagen consists of three
identical pro-α1(III) chains (encoded by COL3A1). Mutations
in these collagen genes lead to osteogenesis imperfecta (OI)
Table 1
Summary of SNPs identified in the four collagen genes
Number of nucleotides sequenceda (bp)
Coding Noncoding
COL1A1 4395 10,095
COL1A2 4101 19.243
COL2A1 4067 16,824
COL3A1 4185 16,948
No. of polymorphic sites detected
Total Novelb Novel with
MAF≥5%b,c
Listed in
dbSNP
but not
seen in
data setb,d
Only one
submitter and/
or no frequency
informationb,e
COL1A1 106 75 17 38 36
COL1A2 98 49 11 44 40
COL2A1 141 83 21 59 54
COL3A1 114 66 11 42 30
aTotal number of nucleotides sequenced: 79,858.
bBased on dbSNP build 126.
cIn at least one population.
dMutations (amino acid changes that involve glycine or proline substitutions)
listed in dbSNP are excluded for comparison as we do not expect to find any in
our healthy cohort.
dSNPs listed in dbSNP as a single submission without any confirmation.
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vascular Ehlers–Danlos syndrome (COL3A1) [4].
Although mutations in these genes and the resulting clinical
phenotypes are widely known, the relationships between geno-
types and clinical phenotypes are not well defined. For example,
the severity of the OI phenotype that results from mutations that
substitute glycine residues in the triple helical domains of the
pro-α chains of Type I procollagen depends on the gene in
which the mutation occurs, the location of the mutation, and the
nature of the substituting amino acid [3]. However, beyond
that general statement, it is difficult to identify precise rules for
prediction of phenotype for a new, previously unseen, mutation.
Understanding the physiochemical properties of native and al-
tered collagens should provide the basis for defining the mole-
cular etiology of the clinical phenotypes. However, phenotype
variation observed in patients carrying the same mutation sug-
gests an influence of the genetic background on which the
specific mutation occurs (the altered allele, the other allele, and
the background interacting genes).
As a first step toward assembling these data, we have re-
sequenced all the coding regions and significant portions of the
intronic and 5′ and 3′ untranslated regions ofCOL1A1, COL1A2,
COL2A1, andCOL3A1 in 48 individuals from each of four ethnic
groups (African American, European, Mexican, and Chinese) in
the SOPHIE (Studies of Pharmacogenetics in Ethnically Diverse
Populations) cohort. We identified 459 single-nucleotide poly-
morphisms (SNPs) in the four collagen genes, 273 of which were
not found in dbSNP. Examination of the molecular evolutionary
characteristics of these naturally occurring variations revealed
significant differences among populations. Correlating collagen
mutationswith background variations in the future should provide
additional insights into the understanding of the molecular
etiology of collagen disorders and toward predicting the mo-
lecular and clinical outcomes of mutations.
Results
SNP discovery
We identified 458 biallelic SNPs and 1 triallelic site (in
COL2A1) in almost 80 kb of genomic sequence (Table 1). Com-
pared with build 126 of dbSNP, 273 of the 459 SNPs are novel.
Sixty of the novel SNPs (22%) are common, with N5% minor
allele frequency (MAF) in at least one population. There are 183
SNPs reported in dbSNP but not found in our sample set. Of
those, 160 are single submissions that have not been validated or
have no associated allele frequency information, suggesting that
they are either very rare or due to errors [13]. The remaining 23
SNPs were missed due to technical reasons: SNPs in close prox-
imity to an insertion/deletion (indel) were masked by the over-
lapping peak patterns, and SNPs too close to the beginning or the
end of a sequencing trace were embedded in poor sequence.
Ethnic differences in themolecular evolution of the collagen genes
Of the 459 SNPs identified, 208 were population-specific
(Supplemental Table 2), with 110 (53%) found only in the AfricanAmerican population, 40 (19%) found only inChineseAmericans,
35 (17%) found only inMexicanAmerican subjects, and 23 (11%)
only in European Americans. Most of the population-specific
SNPs we identified were novel (187 of 208) and their minor allele
frequencies were low. Overall, 16/110 (15%) African American-
specific variants had MAF≥0.05, 5/40 (12.5%) Chinese Amer-
ican-specific variants had MAF≥0.05, and only one European
American-specific variant (of 23) had MAF≥0.05. None of the
Mexican American-specific variants had MAF≥0.05.
Fig. 1 is a visual overview of all the common SNPs
(MAF≥0.05) found in the four genes. Samples within each
ethnic group were clustered based on the genotype data using
the VG2 program (http://pga.gs.washington.edu/VG2.html).
(Clustered maps that include all variants found in each of the
four collagen genes are included as Supplemental Figs. 1a–d.)
We noticed that (i) the European American and the Mexi-
can American data sets shared very similar allelic structures in
COL1A1, COL1A2, and COL3A1; (ii) the African American and
the Chinese American data sets showed very different structures
from the other two groups; and (iii) COL2A1 was markedly
different from the other three collagen genes, as it uniquely ex-
hibited high heterozygosity across all four ethnicities.
To verify our initial observations, we used the allele fre-
quencies at all polymorphic sites with MAF≥0.05 to calculate
the Reynolds distances between the four ethnic groups for each
gene, and we used PHYLIP to generate the phylogenetic trees in
Fig. 2. Results shown in Fig. 2 confirmed our initial observations.
In addition, for the Type I collagen genes COL1A1 and COL1A2
the Chinese Americans were most distinct from all other groups.
This was not the case for COL3A1, in which the African Ame-
ricans were evolutionarily separated from the rest. The phyloge-
netic tree for COL2A1 had a unique topology compared to the
Fig. 1. A visual genotype map of all common alleles (MAF≥0.05) in the four collagen genes. SNPs in each gene are arranged from 5′ (left) to 3′ (right). Each row
represents an individual in one of the four ethnic groups: African American (black), European American (blue), Mexican American (green), and Chinese American
(red). Homozygous major alleles are represented in blue, heterozygous loci in green, and homozygous minor alleles in yellow. Within each ethnic group, individuals
were further clustered by samples using the VG2 program available from the Nickerson group at SeattleSNP (http://pga.gs.washington.edu/VG2.html).
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lutionary history that differentiated the four ethnic groups most
clearly.
Selection characteristics of the collagen genes
To understand further the patterns of natural variation in the
four collagen genes, we computed two descriptors for nucleotide
diversity, the average heterozygosity (π) and the population
genetic parameter (θ) [8]. These two distinct numerical descrip-
tors, one measuring the allele frequency spectrum and the other
the rate of polymorphism, were used to calculate Tajima's D, a
statistic that detects deviations from the neutral mutation model
[9]. The beta distribution of Tajima's D (between –1.782 and
2.072 for n=96 and at 95% confidence interval) assumes that
polymorphism ascertainment is independent of allele frequency
spectrum, i.e., no selection is in force. A highly positive Tajima's
D value indicates an excess of common variations in a region and
suggests a possible heterozygote advantage, whereas a negative
Tajima's D is indicative of an excess of rare variants, consistentwith negative selection. These parameters were calculated for
the entire sequenced region as well as for individual sequence
classes (coding versus noncoding and synonymous versus non-
synonymous changes) and the results were grouped either by
ethnicity (Supplemental Table 2) or by gene (Supplemental Table
3). In summary, only the coding region in COL1A1 had
significantly negative Tajima's D values, which ranged from
–2.61 to–2.38 (highlighted in boldface in Supplemental Table 2),
suggesting that the coding region of COL1A1 is under negative
selective pressure.
The Tajima'sD test was designed to test whether there are too
few or too many rare variants compared to common ones, but it
does not address the relative abundance of those that are of high-
and low-frequency classes. Zeng et al. recently proposed a new
statistical test, the E test, to probe for positive selection by con-
trasting high- and low-frequency variants [10]. In the Chinese
American data set as well as in the gene COL2A1 we observed
the presence of many high-frequency variants, suggesting that a
positive selection might be at work. We employed the E test to
detect positive selection for all four collagen genes in each of
Fig. 2. Phylogenetic trees for the four collagen genes. Genotype data from Fig. 1 were used to determine the four-way Reynolds distances and phylogenetic trees were
generated using the PHYLIP software package.
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p=0.001, none of the values from the E test indicated that a
significant positive selection force is in place. However, the
COL2A1 gene in Chinese Americans showed the highest E-test
value. It was particularly obvious in some of the regions of the
gene that we examined (data not shown).
The ratio of nonsynonymous to synonymous changes (πNS/
πS) provides a way to assess the degree of negative selection in
the coding region of a gene, on the assumption that deleterious
alleles are in low abundance and that synonymous changes
reflect selection [14]. For COL1A1 and COL1A2 the ratios were
significantly less than 1, suggesting that they are under negative
selection (Supplemental Table 3). The ratios for COL2A1 and
COL3A1 were close to 1, suggesting that they are under little
or no negative selective pressure.
All the coding SNPs identified in this study were listed in
Table 2. As a recurring theme in our observations, COL1A1 was
devoid of common variants in the coding region, whereas rela-
tively common nonsynonymous SNPs (MAF≥0.05) could be
found in the other three collagen genes: A549P (COL1A2), S9T,
G1336S (both in COL2A1), and T698A (COL3A1). Genome-
wide codon usage in human has been previously assessed by
determining the relative synonymous codon usage (RSCU [15])
values from more than 80,000 human coding sequences (http://
www.kazusa.or.jp/codon). In our data set, a majority of the
synonymous changes with significant alterations in RSCUvalues—greater than 50% changes and in boldface in Table 2—
involved the glycine residue. Based on these global RSCU
values, almost all of them except for Gly543 in COL2A1 and
Gly748 in COL3A1 changed a more commonly used codon to
the least used codon, GGU. Some of these variants had average
MAF≥0.05, such as Val626 and Gly1054 in COL1A2 and
Gly696 in COL2A1.
Insertion–deletion polymorphisms
We observed 26 noncoding indels (or about 5% of the total
polymorphisms identified) in the noncoding sequences only.
Discussion
The collagens encoded by the four genes we studied are some
of the most important structural proteins in humans and other
higher organisms. Our data showed that the four collagen genes
we resequenced have different molecular evolutionary character-
istics. In addition, phylogenetic analysis suggests that the four
genes have very different evolutionary histories in the four ethnic
groups we examined. Careful consideration of these character-
istics may lead to new insights into the genotype–phenotype
relationships in patients with collagen gene mutations and
the evolutionary history of these structural genes in various
populations.
Table 2
Coding SNPs in the four collagen genes
Coding SNPsa Syn. codon changesb RSCU changesc AAd MEXd CHId EURd rs number (dbSNP)e
COL1A1 R59R CGG→ CGU 11.5→ 4.6 0.05 — — — 1057297
G154G GGC→ GGU 22.3→ 10.8 — — 0.01 — —
V607V GUC→ GUU 14.5→ 11.0 0.01 — — — —
N705N AAC→ AAU 19.1→ 16.9 — 0.01 — — —
G725G GGC→ GGU 22.3→ 10.8 0.01 — — — —
A1075T — — 0.06 0.01 — 0.01 1800215
V1081V GUU→ GUC 11.0→ 14.5 — — — 0.01 1800217
R1141Q — — — — 0.01 — —
D1153D GAU→ GAC 21.8→ 25.2 0.10 0.01 — — 1800218
V1177I — — — — 0.01 — —
K1371K AAG→ AAA 31.9→ 24.3 0.02 — — — —
S1393S UCC → UCU 17.7→ 15.1 0.01 0.01 — — 1800219
T1419T ACC → ACU 18.9→ 13.1 0.01 — — — —
COL1A2 T29T ACC → ACU 18.9→ 13.1 0.34 0.05 0.45 0.02 1801182
D82D GAU→ GAC 21.8→ 25.2 0.60 0.13 0.49 0.19 1800222
P482P CCA→ CCC 16.9→ 19.8 0.41 0.40 0.27 0.37 412777
N528S — — 0.01 — — — —
A549P — — 0.18 0.26 0.09 0.30 42524
A564T — — — — 0.01 — —
V626V GUG→ GUU 28.2→ 11.0 0.01 0.07 0.46 0.02 1800238
F850F UUC→ UUU 20.4→ 17.5 — — 0.01 — —
G1054G GGC→ GGU 22.3→ 10.8 0.07 0.05 0.06 0.09 1800248
COL2A1 S9T — — 0.31 0.42 0.50 0.19 3803183
E73D — — 0.02 0.03 — 0.03 —
G99G GGC→ GGA 22.3→ 16.5 0.16 0.21 0.32 0.17 3737548
R446R CGC → CGA 10.5→ 6.2 — 0.01 — — —
G543G GGU→ GGC 10.8→ 22.3 — — — 0.01 —
T569I — — — — 0.04 — —
D613D GAC→ GAU 25.2→ 21.8 — 0.01 — — —
G696G GGC→ GGU 22.3→ 10.8 0.03 0.01 0.13 0.04 2276454
N731N AAU→ AAC 16.9→ 19.1 0.44 0.27 0.50 0.30 1635553
G759G GGG→ GGC 16.4→ 22.3 0.01 0.02 — — 1793940
G822G GGC→ GGG 22.3→ 16.4 — — 0.07 0.03 —
P931P CCG→ CCA 6.9→ 16.9 0.09 0.01 — — 1793947
A982T — — — 0.01 — — —
V1262I — — 0.01 0.02 0.02 0.07 12721427
G1287G GGC→ GGU 22.3→ 10.8 0.16 — 0.02 0.01 17122498
P1299P CCC → CCU 19.8→ 17.5 — 0.01 — 0.01 12721379
G1336S — — 0.04 0.38 0.45 0.11 2070739
G1356G GGC→ GGU 22.3→ 10.8 0.01 — — — —
P1414P CCG→ CCA 6.9→ 16.9 0.02 — — — —
COL3A1 G177G GGC→ GGA 22.3→ 16.5 — 0.01 — — —
A419A GCC → GCU 27.9→ 18.5 0.07 0.01 — — —
P553P CCU→ CCA 17.5→ 16.9 0.02 — — — —
L643L UUG→ CUG 12.9→ 39.8 — 0.01 — — —
A679T — — — 0.01 — 0.01 —
T698A — — 0.09 0.31 0.23 0.26 1800255
G748G GGU→ GGC 10.8→ 22.3 0.30 0.17 0.05 0.24 1801184
N986N AAC→ AAU 19.1→ 16.9 — — 0.01 — —
V1205I — — 0.01 — 0.05 — 2271683
P1218P CCG→ CCU 6.9→ 17.5 0.03 — — — —
Q1353H — — 0.02 — — — 1516446
aNonsynonymous SNPs are in bold, novel SNPs are in italics.
bOnly codons for synonymous amino acid changes are listed.
cRSCU (relative synonymous codon usage) values for the human genome were obtained from the Codon Usage Database (http://www.kazusa.or.jp/codon/cgi-bin/
showcodon.cgi?species=Homo+sapiens+[gbpri]). Changes in RSCU of more than 50% (either increase or decrease) are highlighted in bold.
dAllele frequency for each of the four populations: AA, African American; MEX, Mexican; CHI, Chinese; and EUR, European.
eReference SNP cluster identifier (http://www.ncbi.nlm.nih.gov/projects/SNP/).
311T.-F. Chan et al. / Genomics 91 (2008) 307–314Rare variants, because they arose recently [16], are more likely
to be population-specific and can serve as sensitive indicators of
recent migration and gene flow among various populations [17].In our study, the Mexican American population shared a sub-
stantial number of rare variants in the four collagen genes with the
African Americans and the European Americans (Supplemental
312 T.-F. Chan et al. / Genomics 91 (2008) 307–314Table 5). By comparison, very few rare variants were shared
between the Chinese Americans and the other three populations.
This pattern of relatedness is consistentwith the history of the four
ethnic groups in the United States, where Mexican Americans
and African Americans are both admixed with European des-
cent [18,19]. We also observed (Fig. 2) a relative closeness be-
tween the Mexican Americans and the European Americans in
COL1A1, COL1A2, and COL3A1. The phylogenetic tree of
COL3A1 reflects the current understanding of human migration
patterns: our common ancestors evolved over time and migrated
out of Africa and eventually settled in geographically separate
areas of the European, Asian, and finally American continents
[20]. This pattern was not seen in the other three collagen genes.
Intriguingly, for COL1A1 and COL1A2, the Chinese Americans
appeared as a much more distant group compared to the African
Americans. Thus, even though the four collagen genes are highly
similar in terms of gene and protein structures, they appear to have
evolved in separate ways. These findings point to a hypothetical
scenario in which ethnic background could play an important role
in affecting the variable expressivity of the same mutation among
different patients, such as a preexisting difference in gene func-
tions (level of gene expression, for example) that are embedded in
the ethnic background of the patient.
Formembers of a class of highly conserved proteins, COL2A1
and COL3A1 had unexpectedly high πNS/πS ratios (0.83 and
0.97, respectively). For example, the average πNS/πS for the ABC
transporters and the SLC transporters is 0.15 and 0.28, re-
spectively [18]. The much higher πNS/πS ratios for COL2A1 and
COL3A1 can be accounted for by the few nonsynonymous SNPs
that exist at high frequencies in our sample set, e.g., G1336S in
COL2A1 (averageMAF=0.24) and T698A inCOL3A1 (average
MAF=0.22) (Table 2). Although it is known that common
nonsynonymous changes are unlikely to have any deleterious
effect [14], the presence of common amino acid substitutions in a
major structural protein in the body suggests that the protein is
under less negative selective pressure than expected.
Although both COL1A1 and COL1A2 had low πNS/πS ratios
(0.38 and 0.21, respectively), only the COL1A1 gene showed
significantly negative Tajima's D values in the coding region
(Supplemental Table 2).COL1A2, on the other hand, had positive
Tajima's D values across all four ethnic groups. The apparent
discrepancy can be accounted for by the many synonymous
SNPs that exist at high frequencies in the COL1A2 coding region
(Table 2), thereby inevitably driving down the πNS/πS ratio. In
addition, Tajima's D is designed to detect whether there is an
excess of rare variants in the region of interest, and since all but
two coding SNPs in COL1A2 were common (MAF≥0.05), this
test is not particularly sensitive. We also noticed that COL1A1
and COL1A2 each have an amino acid substitution presenting at
relatively high frequencies (A1075T in COL1A1; A549P in
COL1A2). Both amino acid changes are located in regions that
were previously mapped to be important for ligand binding [21].
A549P, in particular, is in the region at which many lethal OI
mutations on the pro-α2(I) chain were found. The fact that an
amino acid change that could introduce a significant alteration to
the protein structure (alanine to proline) is present at high fre-
quency within a healthy population should provide importantinsights for the study of the relationships between collagen
mutations and their clinical manifestations.
Synonymous changes in coding regions, i.e., changes in codon
usage, are usually overlooked, as the resultant amino acid chain
remains the same, and the variant should not manifest any dis-
cernable effect. However, at least two recent independent studies
reported that synonymous changes can affect either the mRNA
stability in the human dopamine receptor D2 (DRD2) gene or the
substrate specificity of the ABC transporter ABCB1 (encoded by
the gene MDR1) [22,23]. Codon usage in the collagen genes is
particularly intriguing when we consider the genome-wide codon
usage in humans. The G nucleotide is rarely used as a third base
for the four codons that encode glycine (GGN) and the four that
encode proline (CCN)—G occurs in only 11 of the 390 (2.8%)
glycine codons in COL1A1 protein and is not found in any of the
278 proline codons. The CCG proline codon is the least used
codon genome wide (RSCU=6.9; compared to RSCUCCU=
17.5). In contrast, unlike for proline, the codonGGG,which codes
for glycine, is in fact more commonly used than GGU in the
human genome (RSCUGGG=16.4; RSCUGGU=10.8).
In COL1A1, 45.1% of the glycine codons, and 50.9% in
COL1A2, are GGU (40.9% in COL2A1; 43.6% in COL3A1);
this marked preference for U as the third base in codons can also
be seen in proline residues [24]. This phenomenon is most
evident in codons for the proline occupying the Yposition in the
Gly-X-Y triplets characteristic of the triple helical domain, in
which the Y residue precedes glycine. The excess of U at the
third position likely represents the accumulation of changes that
occurred at historical CCC proline codon followed by a GGN
glycine codon. If the CpG dinucleotide was altered by cytosine
methylation and deamination, a T would be generated in place
of the C. If the alteration of the C occurred on the noncoding
strand equivalent, the effect would be to alter that glycine
codon, a highly deleterious mutation. With their unique coding
sequence, the collagen genes may therefore have a unique
evolutionary history as seen in our study.
Large-scale screens have devoted very little attention to in-
dels as natural variation until a recent study by Mills et al. [25],
which reported a whole-genome map of indels identified by
DNA resequencing in 36 individuals. That study reported 10
noncoding indels in the four collagen genes. In contrast, our
study observed 26 noncoding indels (or about 5% of the total
polymorphisms identified). Although we observed more in-
dels, the number was still low compared to previous studies on
other genes. For example, Wang et al. reported 10 indels in 71
SNPs (∼14%) from screening the multidrug resistance-
associated protein MRP1 in 142 samples from four different
populations, even though they observed an evolutionary con-
straint on the gene [26]. In another study, Leabman et al.
reported 8 indels in the coding regions from a set of 24 mem-
brane transporter genes [18]. Unlike membrane transporters
and other nonstructural protein genes, the four collagen genes
encode collagen propeptides that form fibrils and therefore
require proper structure and function for all units. Variants that
disrupt the integrity of the coding sequence, even at a heter-
ozygous state, can act as dominant negative mutations. The
complete absence of coding indels in our data set is consistent
313T.-F. Chan et al. / Genomics 91 (2008) 307–314with the detrimental consequences of any frame-shift or trun-
cation to the collagen protein structures.
Recently, several groups reported that a deficiency in prolyl
3-hydroxylase 1, responsible for a critical posttranslational mo-
dification in the fibrillar collagen chains, results in a recessive
form of OI [27–29]. These recent findings demonstrate that,
despite the use of the collagen protein as the classic textbook
example of a structural protein for more than 2 decades, much of
the biology that determines its synthesis, chain assembly, and
functions remains understood only in outline. Our study begins
with a systematic investigation into allelic variations in the
collagen genes. The evolutionary characteristics of these genes
may help to explain and understand phenotypic effects that are
difficult to comprehend solely on the basis of mutations.
Materials and methods
Subject population
DNA samples were collected from a cohort of 192 unrelated individuals (48
African Americans, 48 European Americans, 48 Mexican Americans, and 48
Chinese Americans; with equal representation from both genders) from the San
Francisco Bay Area enrolled in the SOPHIE project (Studies of Pharmacoge-
netics in Ethnically Diverse Populations). These individuals had no known
genetic or acquired disorders at the time of sampling and had all four grand-
parents of the same population origin.
Variant identification and verification
The structures of the four collagen genes share an intriguing feature: most of
the exons are 54 bp long and the rest are either 2 times 54, 3 times 54, or a
combination of 45 and 54 bp [1]. Due to their small sizes and the close proximity
of many exons to each other, we designed amplicons with an average size of
1.2 kb. Introns located between such nearby exons were completely sequenced.
We also used the VISTA tool [5] to align each human collagen gene with its
mouse counterpart and looked for noncoding regions with sequence conservation
greater than 70%. Intron 1 (between the first and the second exons) in COL1A1,
COL1A2, and COL2A1 is several kilobase pairs in size and contains several
clusters of highly conserved sequences. These regions were also included in our
resequencing effort.
We sequenced all coding regions, intron sequences for at least 100 bp on
either side of each exon, and the evolutionarily conserved domains in noncoding
regions, covering a total of 80 kb of the total 140 kb genomic length of all four
genes (COL1A1, COL1A2, COL2A1, and COL3A1). Typically, fragments of 1 to
1.5 kb were amplified with primers designed to include the largest amount of
coding sequence. Except for fragments of sizes smaller than 700 bp and were
sequenced in one direction, the rest were sequenced in both directions. Primer
sequences, PCR conditions, and sequence coordinates of each fragment are
available in the supplementary materials (Supplemental Table 1). Primers were
designed using the program Primer3 [6] or were previously designed and tested.
All primers were synthesized by Integrated DNATechnologies (Coralville, IA,
USA). Each PCR included 4 ng of genomic DNA from a pool of two individuals
(of the same ethnicity and gender) and 1 μM each forward and reverse primer.
The PCR protocol was based on the PlatinumTaq kit from Invitrogen (Carlsbad,
CA, USA) with slight modifications. The PCR cycling conditions were as fol-
lows: 2-min incubation at 95 °C to denature the genomic DNA and activate the
polymerase, followed by 35 cycles of amplification: denaturation for 10 s at
92 °C, primer annealing for 20 s at appropriate temperature, and extension for
1 min at 72 °C. The samples were held for 10 min at 72 °C for final extension.
PCR products were purified by the cleanup reagent ExoSAP-IT (USB Corp.,
Cleveland, OH, USA) to remove unincorporated dNTPs and PCR primers. The
purified products were sequenced using the BigDye Terminator v3.1 cycle
sequencing kit (Applied Biosystems, Foster City, CA, USA). The sequencing
products were filter-purified using genCLEAN dye terminator cleanup plates(Genetix USA, Boston, MA, USA) and read in the ABI 3730xl DNA analyzer
(Applied Biosystems). Sequence traces were aligned with the reference
sequence retrieved from the UCSC genome browser (http://genome.ucsc.edu/
cgi-bin/hgGateway) [7] and scored in Sequencher v4.7 (Gene Codes Corp., Ann
Arbor, MI, USA).
All singleton SNPs were resequenced. Amplicons containing one or more
SNP with a MAF greater than 5% were resequenced in individuals to generate
data for analysis. All variants identified in this study have been deposited with
the public databases PharmGKB (http://www.pharmgkb.org) and dbSNP (www.
ncbi.nlm.nih.gov/projects/SNP/).
Population genetics parameters
Under the assumption of an infinite-sites neutral-allele model, the population
genetic parameter (θ) and the average heterozygosity (π) estimators of nu-
cleotide diversity were calculated [8] for each gene and separately for coding
and noncoding regions in each population. We also used Tajima's D statistics to
measure departure from the expected patterns of neutral variation [9]. To test for
the presence of positive selection, we employed the E test, which is especially
sensitive to high-frequency variants [10].
Phylogenetic analysis
Genetic distances are used to measure the global genetic difference between
two populations. Reynolds distance assumes that the differences between any
two populations have arisen primarily due to genetic drift [11]. For each of the
four collagen regions, COL1A1, COL1A2, COL2A1, and COL3A1, we used
Reynolds distance to compute the genetic distance from a set of gene fre-
quencies in the different ethnic groups.
Trees are the most common method of phylogenetic analysis. The tree
topology and branch lengths represent historical events such as splitting and
separations. We used the Fitch and Margoliash method, which assumes that the
amount of evolution between two groups as depicted by a branch length is
directly proportional to the genetic distance observed between them [12]. We
used the Gendist program from the PHYLIP package version 3.6 (http://
evolution.genetics.washington.edu/phylip.html) to generate the distance matrix
for the four ethnic groups using the genotype data, followed by the Fitch pro-
gram to generate the trees.Acknowledgments
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